BrokerLens

Emcure Pharmaceuticals Limited IPO (EMCURE)

Status
Listed
Security type
Mainboard
Price band
Rs.960 to Rs.1008
Final issue price
Rs 1008
Issue size
Not disclosed
Bidding opens
3 July 2024
Bidding closes
5 July 2024
Listing date
10 July 2024

Facts are NSE's own public-issue disclosures, refreshed periodically. Not investment advice; BrokerLens does not publish grey market premium (GMP) or recommend any IPO.

Sponsored
Zerodha

Brokerage-free equity & mutual fund investments

Trade with Zerodha's Kite platform and tools.

  • Zero brokerage on equity delivery
  • ₹20 flat for intraday, F&O, currency and commodity*
  • Free direct mutual fund investing
Open account →
*T&C apply. Investment in securities market are subject to market risks; read all related documents carefully before investing. Full disclaimer at zerodha.com/pricing. Member ID NSE (13906), BSE (6498), MCX (46025).
Sponsored
5paisa

Flat ₹20 per order, every segment

Trade stocks, derivatives and more on 5paisa's platform.

  • ₹20 flat for delivery, intraday and F&O
  • Free account opening
  • Listed on NSE and BSE
Open account →
*T&C apply. Investment in securities market are subject to market risks; read all related documents carefully before investing. SEBI Registration: INZ000010231.

Frequently asked questions

What is the price band for the Emcure Pharmaceuticals Limited IPO?

The Emcure Pharmaceuticals Limited IPO price band is Rs.960 to Rs.1008 per share.

When does the Emcure Pharmaceuticals Limited IPO open and close?

Bidding opens 3 July 2024 and closes 5 July 2024.

Is the Emcure Pharmaceuticals Limited IPO a mainboard or SME issue?

Emcure Pharmaceuticals Limited is a mainboard IPO, listing on NSE's main board.

When did the Emcure Pharmaceuticals Limited IPO list?

Emcure Pharmaceuticals Limited listed on 10 July 2024.

Does this page show the grey market premium (GMP) for Emcure Pharmaceuticals Limited?

No. GMP is an unregulated, off-exchange estimate BrokerLens does not publish - see methodology. This page shows only NSE's own disclosed facts and, once bidding opens, NSE's own published subscription figures.

Is investing in the Emcure Pharmaceuticals Limited IPO recommended by BrokerLens?

No. BrokerLens does not recommend any IPO, stock or broker. This page states public facts only; it is not investment advice.